Morin C, Joly P, Courville P, Young P, Richard C, Balguerie X, et al. Chronic eczematiform eruption in the elderly. Ann Dermatol Venereol. 2002;2002:19–22.
Joly P, Benoit-Corven C, Lambert A, Hellot M, Josset V, Barbaud A, et al. Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case–control study. J Invest Dermatol. 2007;127(12):2766–71.
Article CAS PubMed Google Scholar
Summers EM, Bingham CS, Dahle KW, Sweeney C, Ying J, Sontheimer RD. Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers. JAMA Dermatol. 2013;149(7):814–8.
Abel MK, Jelousi S, Berger T, Murase JE, Butler DC. Immunological eruptions of ageing: reframing chronic pruritic rashes in older adults. Br J Dermatol. 2021;185(3):638–9.
Article CAS PubMed Google Scholar
Berger TG, Steinhoff M. Pruritus in elderly patients—eruptions of senescence. Semin Cutan Med Surg. 2011;30(2):113–7.
Article CAS PubMed PubMed Central Google Scholar
Tanei R. Clinical characteristics, treatments, and prognosis of atopic eczema in the elderly. J Clin Med. 2015;4(5):979–97.
Article CAS PubMed PubMed Central Google Scholar
Tétart F, Joly P. Eczema in elderly people. Eur J Dermatol. 2020;30(6):663–7.
Lee HH, Patel KR, Singam V, Rastogi S, Silverberg JI. A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am Acad Dermatol. 2019;80(6):1526-32.e7.
Laube S. Skin infections and ageing. Ageing Res Rev. 2004;3(1):69–89.
Beckman AGK, Parker MG, Thorslund M. Can elderly people take their medicine? Patient Educ Couns. 2005;59(2):186–91.
Lisberg R,Higham C, Jayson M. Problems for rheumatic patients in opening dispensed drug containers. Br J Rheumatol. 1983;22(2):95–8.
Arlt S, Lindner R, Rösler A, von Renteln-Kruse W. Adherence to medication in patients with dementia. Drugs Aging. 2008;25(12):1033–47.
Joray S, Wietlisbach V, Büla C. Cognitive impairment in elderly medical inpatients: detection and associated six-month outcomes. Am J Geriatr Psychiatry. 2004;12(6):639–47.
Wilson IB, Schoen C, Neuman P, Strollo MK, Rogers WH, Chang H, et al. Physician-patient communication about prescription medication nonadherence: a 50-state study of America’s seniors. J Gen Intern Med. 2007;22(1):6–12.
Article PubMed PubMed Central Google Scholar
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
Article CAS PubMed Google Scholar
Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 2001;35(5):539–45.
Article CAS PubMed Google Scholar
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.
Article CAS PubMed Google Scholar
Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among medicare beneficiaries. Health Aff. 2003;22(4):220–9.
Farage MA, Miller KW, Sherman SN, Tsevat J. Assessing quality of life in older adult patients with skin disorders. Glob J Health Sci. 2012;4(2):119–31.
Article PubMed PubMed Central Google Scholar
Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–7.
Eckert L, Gupta S, Amand C, Gadkari A, Mahajan P, Gelfand JM. Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey. J Am Acad Dermatol. 2017;77(2):274-9.e3.
Pieterse AH, Finset A. Shared decision making—much studied, much still unknown. Patient Educ Couns. 2019;102(11):1946–8.
Katsarou A, Armenaka MC. Atopic dermatitis in older patients: particular points. J Eur Acad Dermatol Venereol. 2011;25(1):12–8.
Article CAS PubMed Google Scholar
Lima AL, Timmermann V, Illing T, Elsner P. Contact dermatitis in the elderly: predisposing factors, diagnosis, and management. Drugs Aging. 2019;36(5):411–7.
Zirwas MJ, Barkovic S. Anti-pruritic efficacy of itch relief lotion and cream in patients with atopic history: comparison with hydrocortisone cream. J Drugs Dermatol. 2017;16(3):243–7.
Fowler JF, Nebus J, Wallo W, Eichenfield L. Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis. J Drugs Dermatol. 2012;11(7):804–7.
Katoh N, Tennstedt D, Abellan van Kan G, Saint Aroman M, Loir A, Bacqueville D, et al. Gerontodermatology: the fragility of the epidermis in older adults. Journal of the European Academy of Dermatology and Venereology. 2018;32(S4):1–20.
Rathi SK, D’Souza P. Rational and ethical use of topical corticosteroids based on safety and efficacy. Indian J Dermatol. 2012;57(4):251–9.
Article PubMed PubMed Central Google Scholar
Weston WL, Fennessey PV, Morelli J, Schwab H, Mooney J, Samson C, et al. Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Investig Dermatol. 1988;90(4):532–5.
Article CAS PubMed Google Scholar
May P, Stein EJ, Ryter RJ, Hirsh FS, Michel B, Levy RP. Cushing syndrome from percutaneous absorption of triamcinolone cream. Arch Intern Med. 1976;136(5):612–3.
Article CAS PubMed Google Scholar
Gomez EC, Frost P. Induction of glycosuria and hyperglycemia by topical corticosteroid therapy. Arch Dermatol. 1976;112(11):1559–62.
Article CAS PubMed Google Scholar
Dhar S, Seth J, Parikh D. Systemic side-effects of topical corticosteroids. Indian J Dermatol. 2014;59(5):460–4.
Article PubMed PubMed Central Google Scholar
Valeant Pharmaceuticals North America LLC. Elidel (pimecrolimus) Cream [package insert]. 2014 [cited 2020 November 12]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021302s018lbl.pdf. Accessed 8 Aug 2021.
Astellas Pharma US. Protopic (tacrolimus) [package insert]. 2011 [cited 2020 November 12]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050777s018lbl.pdf. Accessed 8 Aug 2021.
Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–82.
Article CAS PubMed Google Scholar
Pereira U, Boulais N, Lebonvallet N, Pennec JP, Dorange G, Misery L. Mechanisms of the sensory effects of tacrolimus on the skin. Br J Dermatol. 2010;163(1):70–7.
Article CAS PubMed Google Scholar
Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. JAAD. 2014;71(1):116–32.
Hanifin JM, Chan SC, Cheng JB, Tofte SJ, Henderson WR, Kirby DS, et al. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Investig Dermatol. 1996;107(1):51–6.
Article CAS PubMed Google Scholar
Bissonnette R, Pavel AB, Diaz A, Werth JL, Zang C, Vranic I, et al. Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial. J Allergy Clin Immunol. 2019;144(5):1274–89.
Article CAS PubMed Google Scholar
Pfizer. Eucrisa (crisaborole ointment) [package insert]. 2016 [cited 2020 November 9]. http://labeling.pfizer.com/ShowLabeling.aspx?id=5331#section-11. Accessed 8 Aug 2021.
Labib A, Does AV, Korbutov J, Yosipovitch G. Silicone barrier cream in treatment of atopic dermatitis: a literature review. Dermatol Ther. 2022;35(12): e15884.
Article CAS PubMed Google Scholar
Panther DJ, Jacob SE. The importance of acidification in atopic eczema: an underexplored avenue for treatment. J Clin Med. 2015;18(4):970–8.
Megna M, Napolitano M, Patruno C, Villani A, Balato A, Monfrecola G, et al. Systemic treatment of adult atopic dermatitis: a review. Dermatol Ther (Heidelb). 2017;7(1):1–23.
Enk CD, Sredni D, Blauvelt A, Katz SI. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol. 1995;154(9):4851.
留言 (0)